Idiopathic pulmonary fibrosis (IPF) is a progressive, eventually fatal disease characterized
by fibrosis of the lung parenchyma and loss of lung function. IPF is believed to be caused by …

Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal disease of unknown
cause characterised by progressive fibrotic formation in lung tissue. We hypothesise that …

Background Idiopathic pulmonary fibrosis (IPF) is a progressive, eventually fatal disease.
IPF is characterized by excessive accumulation of the extracellular matrix (ECM) in the …

The heterogeneity of idiopathic pulmonary fibrosis (IPF) limits its diagnosis and treatment.
The association between the pathophysiological features and the serum protein signatures …

Idiopathic pulmonary fibrosis (IPF) is a gradual lung disease with a survival of less than 5
years post-diagnosis for most patients. Poor molecular description of IPF has led to …

Background Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease of unknown etiology.
Patients present loss of lung function, dyspnea and dry cough. Diagnosis requires …

Background Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease
characterized by progressive loss of the alveolar integrity, recruitment, and activation of …

Idiopathic pulmonary fibrosis (IPF) is a fibroproliferative disorder limited to the lung. New
findings, starting from our proteomics studies on IPF, suggest that systemic involvement with …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease for which no effective
therapy exists to date. To identify the molecular mechanisms underlying IPF, we performed …

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disorder of unknown origin and
the most common interstitial lung disease. It progresses with the recruitment of fibroblasts …